# Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects

> **NCT00648284** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 1100 (—)

## Conditions studied

- Type 2 Diabetes Mellitus
- CV Risk

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00648284
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 1100 (—)
- **Last updated:** 2008-10-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00648284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00648284, "Cardiovascular (CV) Risk Evaluation In Type 2 Diabetes Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00648284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*